Similar to previously reported, 4-methylesculetin improved clinical, histopathological, and biochemical parameters, such as GSH levels and MPO activity (Figure 5) in both acute and subchronic phases of the TNBS-induced intestinal inflammation model [53]. This evidence concerns the gene MPO and gastroenteritis.